A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
NCT01386658
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Hereditary Angioedema (HAE)
Interventions
DRUG:
icatibant
Sponsor
Shire